BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 29 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $82,211 | -54.2% | 249,123 | 0.0% | 0.00% | -100.0% |
Q4 2022 | $179,369 | -40.0% | 249,123 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $299,000 | +1.0% | 249,123 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $296,000 | -45.0% | 249,123 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $538,000 | +45.0% | 249,123 | 0.0% | 0.00% | +50.0% |
Q4 2021 | $371,000 | -49.0% | 249,123 | 0.0% | 0.00% | -33.3% |
Q3 2021 | $727,000 | -11.6% | 249,123 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $822,000 | -12.3% | 249,123 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $937,000 | +6.6% | 249,123 | 0.0% | 0.00% | +33.3% |
Q4 2020 | $879,000 | -46.3% | 249,123 | 0.0% | 0.00% | -57.1% |
Q3 2020 | $1,637,000 | -11.6% | 249,123 | 0.0% | 0.01% | -12.5% |
Q2 2020 | $1,851,000 | +57.8% | 249,123 | 0.0% | 0.01% | +14.3% |
Q1 2020 | $1,173,000 | – | 249,123 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 448,101 | $537,000 | 0.11% |
Long Focus Capital Management, LLC | 327,692 | $393,000 | 0.04% |
Boxer Capital, LLC | 56,950 | $68,000 | 0.00% |
SHUFRO ROSE & CO LLC | 12,941 | $16,000 | 0.00% |
Baker Brothers Advisors | 249,123 | $299,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 45,057 | $54,000 | 0.00% |
Orion Capital Management LLC | 500 | $1,000 | 0.00% |
Parallel Advisors, LLC | 10 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 779 | $1,000 | 0.00% |
NORTHERN TRUST CORP | 10,981 | $13,000 | 0.00% |